295 related articles for article (PubMed ID: 28208209)
1. Emergence of TNIK inhibitors in cancer therapeutics.
Yamada T; Masuda M
Cancer Sci; 2017 May; 108(5):818-823. PubMed ID: 28208209
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic targets in the Wnt signaling pathway: Feasibility of targeting TNIK in colorectal cancer.
Masuda M; Sawa M; Yamada T
Pharmacol Ther; 2015 Dec; 156():1-9. PubMed ID: 26542362
[TBL] [Abstract][Full Text] [Related]
3. TNIK inhibition abrogates colorectal cancer stemness.
Masuda M; Uno Y; Ohbayashi N; Ohata H; Mimata A; Kukimoto-Niino M; Moriyama H; Kashimoto S; Inoue T; Goto N; Okamoto K; Shirouzu M; Sawa M; Yamada T
Nat Commun; 2016 Aug; 7():12586. PubMed ID: 27562646
[TBL] [Abstract][Full Text] [Related]
4. Structural Insight into TNIK Inhibition.
Kukimoto-Niino M; Shirouzu M; Yamada T
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361804
[TBL] [Abstract][Full Text] [Related]
5. Targeting the Wnt signaling pathway in colorectal cancer.
Sawa M; Masuda M; Yamada T
Expert Opin Ther Targets; 2016; 20(4):419-29. PubMed ID: 26439805
[TBL] [Abstract][Full Text] [Related]
6. Traf2- and Nck-interacting kinase is essential for Wnt signaling and colorectal cancer growth.
Shitashige M; Satow R; Jigami T; Aoki K; Honda K; Shibata T; Ono M; Hirohashi S; Yamada T
Cancer Res; 2010 Jun; 70(12):5024-33. PubMed ID: 20530691
[TBL] [Abstract][Full Text] [Related]
7. Liquidambaric acid inhibits Wnt/β-catenin signaling and colon cancer via targeting TNF receptor-associated factor 2.
Yan R; Zhu H; Huang P; Yang M; Shen M; Pan Y; Zhang C; Zhou X; Li H; Ke X; Zhang W; Hao P; Qu Y
Cell Rep; 2022 Feb; 38(5):110319. PubMed ID: 35108540
[TBL] [Abstract][Full Text] [Related]
8. Direct conversion of osteosarcoma to adipocytes by targeting TNIK.
Hirozane T; Masuda M; Sugano T; Sekita T; Goto N; Aoyama T; Sakagami T; Uno Y; Moriyama H; Sawa M; Asano N; Nakamura M; Matsumoto M; Nakayama R; Kondo T; Kawai A; Kobayashi E; Yamada T
JCI Insight; 2021 Feb; 6(3):. PubMed ID: 33400690
[TBL] [Abstract][Full Text] [Related]
9. Discovery of 4-phenyl-2-phenylaminopyridine based TNIK inhibitors.
Ho KK; Parnell KM; Yuan Y; Xu Y; Kultgen SG; Hamblin S; Hendrickson TF; Luo B; Foulks JM; McCullar MV; Kanner SB
Bioorg Med Chem Lett; 2013 Jan; 23(2):569-73. PubMed ID: 23232060
[TBL] [Abstract][Full Text] [Related]
10. The kinase TNIK is an essential activator of Wnt target genes.
Mahmoudi T; Li VS; Ng SS; Taouatas N; Vries RG; Mohammed S; Heck AJ; Clevers H
EMBO J; 2009 Nov; 28(21):3329-40. PubMed ID: 19816403
[TBL] [Abstract][Full Text] [Related]
11. Synergistic inhibition effect of TNIK inhibitor KY-05009 and receptor tyrosine kinase inhibitor dovitinib on IL-6-induced proliferation and Wnt signaling pathway in human multiple myeloma cells.
Lee Y; Jung JI; Park KY; Kim SA; Kim J
Oncotarget; 2017 Jun; 8(25):41091-41101. PubMed ID: 28467797
[TBL] [Abstract][Full Text] [Related]
12. Traf2- and Nck-interacting kinase is essential for canonical Wnt signaling in Xenopus axis formation.
Satow R; Shitashige M; Jigami T; Honda K; Ono M; Hirohashi S; Yamada T
J Biol Chem; 2010 Aug; 285(34):26289-94. PubMed ID: 20566648
[TBL] [Abstract][Full Text] [Related]
13. TNIK influence the effects of antipsychotics on Wnt/β-catenin signaling pathway.
Yuan R; Li Y; Fu Y; Ning A; Wang D; Zhang R; Yu S; Xu Q
Psychopharmacology (Berl); 2021 Nov; 238(11):3283-3292. PubMed ID: 34350475
[TBL] [Abstract][Full Text] [Related]
14. Fragment growth-based discovery of novel TNIK inhibitors for the treatment of colorectal cancer.
Teng Y; Wu R; Bo W; Tang M; Wang T; Cui X; Li Y; Zhang C; Ma Z; Fu Z; Xu Q; Liu J; Chen L
Eur J Med Chem; 2024 Mar; 268():116240. PubMed ID: 38422698
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer.
Cheng X; Xu X; Chen D; Zhao F; Wang W
Biomed Pharmacother; 2019 Feb; 110():473-481. PubMed ID: 30530050
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of Targeting Traf2-and-Nck-Interacting Kinase in Synovial Sarcoma.
Sekita T; Yamada T; Kobayashi E; Yoshida A; Hirozane T; Kawai A; Uno Y; Moriyama H; Sawa M; Nagakawa Y; Tsuchida A; Matsumoto M; Nakamura M; Nakayama R; Masuda M
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32429395
[TBL] [Abstract][Full Text] [Related]
17. Traf2- and Nck-interacting kinase (TNIK) is involved in the anti-cancer mechanism of dovitinib in human multiple myeloma IM-9 cells.
Chon HJ; Lee Y; Bae KJ; Byun BJ; Kim SA; Kim J
Amino Acids; 2016 Jul; 48(7):1591-9. PubMed ID: 26995282
[TBL] [Abstract][Full Text] [Related]
18.
Tanaka N; Mashima T; Mizutani A; Sato A; Aoyama A; Gong B; Yoshida H; Muramatsu Y; Nakata K; Matsuura M; Katayama R; Nagayama S; Fujita N; Sugimoto Y; Seimiya H
Mol Cancer Ther; 2017 Apr; 16(4):752-762. PubMed ID: 28179481
[TBL] [Abstract][Full Text] [Related]
19. Computational study on new natural compound inhibitors of Traf2 and Nck-interacting kinase (TNIK).
Ma L; Li R; Yao Z; Wang B; Liu Y; Liu C; Wang H; Chen S; Sun D
Aging (Albany NY); 2022 Oct; 14(20):8394-8410. PubMed ID: 36287174
[TBL] [Abstract][Full Text] [Related]
20. Discovery of 3,4-Dihydrobenzo[
Li Y; Zhang L; Yang R; Qiao Z; Wu M; Huang C; Tian C; Luo X; Yang W; Zhang Y; Li L; Yang S
J Med Chem; 2022 Feb; 65(3):1786-1807. PubMed ID: 34985886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
